AI-powered X-ray for earlier detection of lung cancer

An AI-enhanced chest X-ray reporting solution has begun trials in NHS Greater Glasgow and Clyde with the aim of improving early detection of lung cancer An AI-enhanced chest X-ray reporting solution has begun trials in NHS Greater Glasgow and Clyde with the aim of improving early detection of lung cancer. In the first three days of the study, almost 250 patients at three hospitals were the first to attend appointments where qXR - a collaboration between Qure.ai, NHSGGC-hosted West of Scotland Innovation Hub, the University of Glasgow and the Scottish Government - was used to analyse chest X-rays in near real-time. Lung cancer is the most common cause of death in Scotland with around 5,500 cases diagnosed each year, predicted to increase by 29% for women and 12% for men by 2027. By detecting cancer earlier, from GP-referred chest X-rays in an outpatient hospital setting, the patient pathway to CT scan or treatment planning can be streamlined. This will save time and potentially improve patients' outcomes and quality of life. The RADICAL (Radiograph Accelerated Detection and Identification of Cancer of the Lung) trial is currently under way at the Inverclyde Royal Hospital in Greenock, the Vale of Leven Hospital in Alexandria and Paisley's Royal Alexandria Hospital. It will be widened to other NHSGGC hospitals in the coming months.